Company: MDCXW
Filing Date: 2025-09-19
Form Type: DRS
Source: 0001062993-25-015719
Chunk: 177

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-19
Form: DRS
Chunk 177
---
 not receive any additional compensation for services rendered in their capacities as directors.

The following table sets forth all compensation awarded to, or earned by, our directors for the year ended December 31, 2024.

| Director             | Fees earned 
      ($)(1) | Share-based 
 Awards      
 ($)         | Option-based 
       Awards 
          ($) | Pension 
 Value   
 ($)     | All Other    
 Compensation 
 ($)          | Total Compensation 
                ($) |
| Dr. Raza Bokhari     |           - | -           |      100,856 | -       | -            |            100,856 |
| Dr. Larry Kaiser     |      60,000 | -           |       30,257 | -       | -            |             90,257 |
| Robert J. Ciaruffoli |      75,000 | -           |       30,257 | -       | -            |            105,257 |
| Frank Lavelle        |      60,000 | -           |       30,257 | -       | -            |             90,257 |
| William L. Ashton    |      50,000 | -           |       30,257 | -       | -            |             80,257 |
| Barry Fishman        |      60,000 | -           |       30,257 | -       | -            |             90,257 |
| Dr. Sara R. May(2)   |      30,000 | -           |       76,051 | -       | -            |            106,051 |

(1)Other than Dr. Raza Bokhari, who did not receive any extra compensation for serving as Executive Chairman, all directors were paid $50,000 annually, in quarterly installments, as compensation for Board membership in 2024. In addition, committee Chairs received an annual compensation of $10,000, other than the Chair of the Audit Committee, who received $15,000, and Mr. Ciaruffoli, as the lead director, who received an additional $10,000 per annum.

(2)Dr. Sara R. May joined the Board in June 2024.

Directors' Service Contracts

There are no arrangements or understandings between us, on the one hand, and any of our directors, on the other hand, providing for benefits upon termination of their service as directors of our company.

Employees

As of the